Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews
Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Stachteas, Dimitrios Patoulias, Konstantinos I. Bougioukas, Nikolaos Fragakis
Topics & Concepts
MedicineHeart failureEjection fractionPlaceboAdverse effectMeta-analysisInternal medicineMEDLINERandomized controlled trialSystematic reviewHeart failure with preserved ejection fractionIntensive care medicineAlternative medicinePathologyLawPolitical scienceDiabetes Treatment and ManagementHeart Failure Treatment and ManagementPotassium and Related Disorders